Unconventional T Cells in the Pancreatic Tumor Microenvironment: Thinking Outside the Box

Sulagna Banerjee, Vikas Dudeja, Ashok Saluja

Research output: Contribution to journalComment/debate

Abstract

Unlike conventional MHC-reactive T cells, unconventional T cells have emerged as an abundant component of the human immune system because of their role in tumor immunology. In this issue of Cancer Discovery, Hundeyin and colleagues have identified a population of unconventional T cells in pancreatic tumors that can reprogram the immune evasive components of the tumor to promote immunogenicity and thus are critical for the development of novel cell-based therapy in pancreatic cancer.See related article by Hundeyin et al., p. 1288.

Original languageEnglish (US)
Pages (from-to)1164-1166
Number of pages3
JournalCancer discovery
Volume9
Issue number9
DOIs
StatePublished - Sep 1 2019

Fingerprint

Tumor Microenvironment
T-Lymphocytes
Neoplasms
Cell- and Tissue-Based Therapy
Allergy and Immunology
Pancreatic Neoplasms
Immune System
Population

ASJC Scopus subject areas

  • Oncology

Cite this

Unconventional T Cells in the Pancreatic Tumor Microenvironment : Thinking Outside the Box. / Banerjee, Sulagna; Dudeja, Vikas; Saluja, Ashok.

In: Cancer discovery, Vol. 9, No. 9, 01.09.2019, p. 1164-1166.

Research output: Contribution to journalComment/debate

@article{8f66ac03c10c4b568365370362768cb6,
title = "Unconventional T Cells in the Pancreatic Tumor Microenvironment: Thinking Outside the Box",
abstract = "Unlike conventional MHC-reactive T cells, unconventional T cells have emerged as an abundant component of the human immune system because of their role in tumor immunology. In this issue of Cancer Discovery, Hundeyin and colleagues have identified a population of unconventional T cells in pancreatic tumors that can reprogram the immune evasive components of the tumor to promote immunogenicity and thus are critical for the development of novel cell-based therapy in pancreatic cancer.See related article by Hundeyin et al., p. 1288.",
author = "Sulagna Banerjee and Vikas Dudeja and Ashok Saluja",
year = "2019",
month = "9",
day = "1",
doi = "10.1158/2159-8290.CD-19-0722",
language = "English (US)",
volume = "9",
pages = "1164--1166",
journal = "Cancer Discovery",
issn = "2159-8274",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Unconventional T Cells in the Pancreatic Tumor Microenvironment

T2 - Thinking Outside the Box

AU - Banerjee, Sulagna

AU - Dudeja, Vikas

AU - Saluja, Ashok

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Unlike conventional MHC-reactive T cells, unconventional T cells have emerged as an abundant component of the human immune system because of their role in tumor immunology. In this issue of Cancer Discovery, Hundeyin and colleagues have identified a population of unconventional T cells in pancreatic tumors that can reprogram the immune evasive components of the tumor to promote immunogenicity and thus are critical for the development of novel cell-based therapy in pancreatic cancer.See related article by Hundeyin et al., p. 1288.

AB - Unlike conventional MHC-reactive T cells, unconventional T cells have emerged as an abundant component of the human immune system because of their role in tumor immunology. In this issue of Cancer Discovery, Hundeyin and colleagues have identified a population of unconventional T cells in pancreatic tumors that can reprogram the immune evasive components of the tumor to promote immunogenicity and thus are critical for the development of novel cell-based therapy in pancreatic cancer.See related article by Hundeyin et al., p. 1288.

UR - http://www.scopus.com/inward/record.url?scp=85071748317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071748317&partnerID=8YFLogxK

U2 - 10.1158/2159-8290.CD-19-0722

DO - 10.1158/2159-8290.CD-19-0722

M3 - Comment/debate

C2 - 31481406

AN - SCOPUS:85071748317

VL - 9

SP - 1164

EP - 1166

JO - Cancer Discovery

JF - Cancer Discovery

SN - 2159-8274

IS - 9

ER -